메뉴 건너뛰기




Volumn 22, Issue 3, 1998, Pages 227-234

A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: Results of a phase II trial

Author keywords

Chemotherapy; Clinical trial; Non small cell lung cancer

Indexed keywords

CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MEGESTROL; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

EID: 0032443183     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(98)00087-7     Document Type: Article
Times cited : (6)

References (26)
  • 2
    • 0023031031 scopus 로고
    • Frequency and prognostic importance of pretreatment and clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy
    • O'Connell J.P., Kris M.G., Gralla R.J. et al. Frequency and prognostic importance of pretreatment and clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy. J Clin Oncol. 4:1986;1604-1614.
    • (1986) J Clin Oncol , vol.4 , pp. 1604-1614
    • O'Connell, J.P.1    Kris, M.G.2    Gralla, R.J.3
  • 3
    • 0026417636 scopus 로고
    • Brief intensive chemotherapy for metastatic non-small cell lung cancer: A phase II study of the weekly CODE regimen
    • Murray N., Osoba D., Shah A. et al. Brief intensive chemotherapy for metastatic non-small cell lung cancer: a phase II study of the weekly CODE regimen. J Natl Cancer Inst. 83:1991;190-194.
    • (1991) J Natl Cancer Inst , vol.83 , pp. 190-194
    • Murray, N.1    Osoba, D.2    Shah, A.3
  • 5
    • 0001184894 scopus 로고
    • A pharmacokinetic hypothesis for the clinical efficacy of etoposide in small cell lung cancer
    • Clark P.I., Joel S.P., Slevin M.L. A pharmacokinetic hypothesis for the clinical efficacy of etoposide in small cell lung cancer. Proc Am Soc Clin Oncol. 8:1989;66.
    • (1989) Proc Am Soc Clin Oncol , vol.8 , pp. 66
    • Clark, P.I.1    Joel, S.P.2    Slevin, M.L.3
  • 6
    • 0023695848 scopus 로고
    • Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide
    • Loehrer P.J., Lauer R., Roth B.J. et al. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med. 109:1988;540-546.
    • (1988) Ann Intern Med , vol.109 , pp. 540-546
    • Loehrer, P.J.1    Lauer, R.2    Roth, B.J.3
  • 7
    • 0022911064 scopus 로고
    • Appetite stimulation with megestrol acetate in cachectic cancer patients
    • Tchekmedyian N.S., Tait N., Moody F. et al. Appetite stimulation with megestrol acetate in cachectic cancer patients. Semin Oncol. 13:1986;37-43.
    • (1986) Semin Oncol , vol.13 , pp. 37-43
    • Tchekmedyian, N.S.1    Tait, N.2    Moody, F.3
  • 8
    • 0027406112 scopus 로고
    • Body composition changes in patients who gain weight while receiving megestrol acetate
    • Loprinzi C.L., Schaid D.J., Dose A.M. et al. Body composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol. 11:1993;152-154.
    • (1993) J Clin Oncol , vol.11 , pp. 152-154
    • Loprinzi, C.L.1    Schaid, D.J.2    Dose, A.M.3
  • 9
    • 0026740918 scopus 로고
    • Granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor
    • Liesschke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor. N Engl J Med. 327:1992;28-35.
    • (1992) N Engl J Med , vol.327 , pp. 28-35
    • Liesschke, G.J.1    Burgess, A.W.2
  • 10
    • 0028302760 scopus 로고
    • Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: A phase I study with apparent activity in non-small cell lung cancer
    • Krigel R.L., Palackdharry C.S., Padavic K. et al. Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small cell lung cancer. J Clin Oncol. 12:1994;1251-1258.
    • (1994) J Clin Oncol , vol.12 , pp. 1251-1258
    • Krigel, R.L.1    Palackdharry, C.S.2    Padavic, K.3
  • 11
    • 0030836373 scopus 로고    scopus 로고
    • Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer
    • Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol. 15:1997;2996-3018.
    • (1997) J Clin Oncol , vol.15 , pp. 2996-3018
  • 12
    • 0024492873 scopus 로고
    • Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC
    • Buccheri G.F., Ferrigno D., Curcio A. et al. Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Cancer. 63:1989;428-432.
    • (1989) Cancer , vol.63 , pp. 428-432
    • Buccheri, G.F.1    Ferrigno, D.2    Curcio, A.3
  • 13
    • 0005574455 scopus 로고    scopus 로고
    • Duration of chemotherapy for advanced non-small cell lung cancer (NSCLC): a phase III randomized trial of 3 versus 6 courses of mitomycin c, vinblastine and cisplatin (MVP)
    • Abstract
    • Smith IE, O'Brien MER, Norton A, et al. Duration of chemotherapy for advanced non-small cell lung cancer (NSCLC): a phase III randomized trial of 3 versus 6 courses of mitomycin c, vinblastine and cisplatin (MVP). Proc ASCO 1998, Abstract 1759.
    • (1998) Proc ASCO , vol.1759
    • Smith, I.E.1    O'Brien, M.E.R.2    Norton, A.3
  • 14
    • 0025800331 scopus 로고
    • Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
    • Crawford J., Ozer H., Stoller R. et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 325:1991;164-170.
    • (1991) N Engl J Med , vol.325 , pp. 164-170
    • Crawford, J.1    Ozer, H.2    Stoller, R.3
  • 15
    • 0027390482 scopus 로고
    • Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy
    • Trillet-Lenoir V., Green J., Manegold C. et al. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer. 29A:1993;319.
    • (1993) Eur J Cancer , vol.29 , pp. 319
    • Trillet-Lenoir, V.1    Green, J.2    Manegold, C.3
  • 16
    • 8044245919 scopus 로고    scopus 로고
    • CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
    • Fukuoka M., Masuda N., Negoro S. et al. CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. Br J Cancer. 75:1997;306-309.
    • (1997) Br J Cancer , vol.75 , pp. 306-309
    • Fukuoka, M.1    Masuda, N.2    Negoro, S.3
  • 17
    • 0028277451 scopus 로고
    • Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small cell lung cancer
    • Eguchi K., Kabe J., Kudo S. et al. Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small cell lung cancer. Cancer Chemother Pharmacol. 34:1994;37-43.
    • (1994) Cancer Chemother Pharmacol , vol.34 , pp. 37-43
    • Eguchi, K.1    Kabe, J.2    Kudo, S.3
  • 18
    • 0026754371 scopus 로고
    • Usefulness of megestrol acetate in cancer cachexia and anorexia
    • Feliu J., Gonzalez-Bron M., Berocal A. et al. Usefulness of megestrol acetate in cancer cachexia and anorexia. Am J Clin Oncol. 15:1992;436-440.
    • (1992) Am J Clin Oncol , vol.15 , pp. 436-440
    • Feliu, J.1    Gonzalez-Bron, M.2    Berocal, A.3
  • 19
    • 0025127861 scopus 로고
    • A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer
    • Bruera E., Macmilan K., Kuehn N. et al. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer. 66:1990;1279-1282.
    • (1990) Cancer , vol.66 , pp. 1279-1282
    • Bruera, E.1    MacMilan, K.2    Kuehn, N.3
  • 20
    • 0027442957 scopus 로고
    • Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer
    • Kornblith A.B., Hollis D.R., Zuckerman E. et al. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. J Clin Oncol. 11:1993;2081-2089.
    • (1993) J Clin Oncol , vol.11 , pp. 2081-2089
    • Kornblith, A.B.1    Hollis, D.R.2    Zuckerman, E.3
  • 21
    • 0027944745 scopus 로고
    • Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia
    • Loprinzi C.L., Bernath A.M., Schaid D.J. et al. Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. Oncology. 51(Suppl 1):1994;2-7.
    • (1994) Oncology , vol.51 , Issue.SUPPL. 1 , pp. 2-7
    • Loprinzi, C.L.1    Bernath, A.M.2    Schaid, D.J.3
  • 22
    • 0028219815 scopus 로고
    • Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy
    • Osoba D., Murray N., Gelmon K. et al. Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy. Oncology. 52:1994;43-49.
    • (1994) Oncology , vol.52 , pp. 43-49
    • Osoba, D.1    Murray, N.2    Gelmon, K.3
  • 23
    • 9044244145 scopus 로고    scopus 로고
    • Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group study
    • Rowland K.M., Loprinzi C.L., Shaw E.G. et al. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol. 14:1996;135-141.
    • (1996) J Clin Oncol , vol.14 , pp. 135-141
    • Rowland, K.M.1    Loprinzi, C.L.2    Shaw, E.G.3
  • 24
    • 0028337478 scopus 로고
    • Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma
    • Veenhof C.H., van der Burg M.E., Aalders N.M. et al. Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma. Eur J Cancer. 30A:1994;697-698.
    • (1994) Eur J Cancer , vol.30 , pp. 697-698
    • Veenhof, C.H.1    Van Der Burg, M.E.2    Aalders, N.M.3
  • 25
    • 0020025773 scopus 로고
    • Occult cancer in patients with acute pulmonary embolism
    • Gore J., Appelbaum J.S., Green H.L. et al. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med. 96:1982;556-560.
    • (1982) Ann Intern Med , vol.96 , pp. 556-560
    • Gore, J.1    Appelbaum, J.S.2    Green, H.L.3
  • 26
    • 0021193823 scopus 로고
    • Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients
    • Goodnough L.T., Saito H., Manni A. et al. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer. 54:1984;1264-1268.
    • (1984) Cancer , vol.54 , pp. 1264-1268
    • Goodnough, L.T.1    Saito, H.2    Manni, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.